NCT04508426View on ClinicalTrials.gov

Single-dose AME Study With [14C]AR882 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

August 12, 2020

Study Completion Date

August 12, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

[14C]AR882

Single dose of \[14C\]AR882

Trial Locations (1)

68502

Celerion, Inc., Lincoln

Sponsors

Lead Sponsor

Arthrosi Therapeutics

Collaborators (1)

All Listed Sponsors

collaborator

Celerion

INDUSTRY

lead

Arthrosi Therapeutics

INDUSTRY

NCT04508426 - Single-dose AME Study With [14C]AR882 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter